Nynikka Palmer, DrPH, MPH

Associate Professor

Dr. Palmer is an Associate Professor at the University of California San Francisco (UCSF), in the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, with secondary appointments in the Departments of Urology and Radiation Oncology. She has a long history and commitment to health equity research. Her research focuses on unraveling the mechanisms of cancer disparities in high-quality cancer care and health outcomes among African Americans, with a depth of knowledge in cultural influence, patient-centered care and communication, and strategies that enhance delivery of high-quality cancer care. Community engagement is the foundation of her work and she strongly believes in the adage, “nothing about me without me,” as patients’ and communities’ perspectives are essential to advance research and optimize health care.

Dr. Palmer currently has a National Cancer Institute-funded career development award to bridge the divide between low-income African American men and equal prostate cancer (PCa) treatment by anchoring the evidence-based intervention of peer navigation in the relational concept of African American brotherhood as a means to foster trust and empowerment, and optimize patient-centered communication and quality of care. She has led and collaborated on various research projects on PCa and patient-provider communication, including a scoping review to characterize the growing body of literature on postoperative patient-initiated communication after hospital discharge. She is co-leader of the Prostate Cancer Task Force of the San Francisco Cancer Initiative (SF CAN), which aims to eliminate PCa disparities among African American men through community and healthcare system engagement to advance education, ensure early detection and appropriate follow-up of aggressive disease, implement navigation and support services, and engage in multiple institutional partnerships that ensure high-quality care throughout the city and county of San Francisco. To promote PCa survivorship, empowerment and patient engagement, she established and oversees two support groups in the San Francisco Bay Area for African American men facing PCa – one that has been thriving since September 2014 and another that was launched January 2020. Several group participants also serve as advisors to her ongoing research program.
Education
DrPH, 2010 - School of Public Health, University of Texas Health Science Center
MPH, 2002 - Rollins School of Public Health, Emory University
BS, 2000 - , Morgan State University
Honors and Awards
  • Health Disparities Research Loan Repayment Program Award., National Institutes of Health – National Institute on Minority Health and Health Disparities, 2021-2023
  • School of Medicine Inaugural Class of Dean’s Population Health and Healthy Equity (PHHE) Scholars, University of California San Francisco, 2018
  • Health Disparities Research Loan Repayment Program, National Institutes of Health – National Institute on Minority Health and Health Disparities, 2016-2017
  • CTSI KL2 Scholar Award, University of California San Francisco, 2016-2017
  • Helen Diller Family Chair in Community Education and Outreach for Urologic Cancer, University of California San Francisco, 2016
  • Center for Aging in Diverse Communities Scholar Award, University of California San Francisco, 2015-2016
  • Distinguished Honoree of the Black Student Health Alliance - 2nd Annual African Heritage Celebration, University of California San Francisco, 2015
  • Health Disparities Research Loan Repayment Program, National Institute on Minority Health and Health Disparities - National Institutes of Health, 2013-2015
Publications
  1. Palmer NR, Smith AN, Campbell BA, Andemeskel G, Tahir P, Felder TM, Cicerelli B. Navigation programs relevant for African American men with prostate cancer: a scoping review protocol. 2022. PMID: 35701771


  2. Samuel Washington, Peter Lonergan, Janet Cowan, Shoujun Zhao, Scott Greenberg, Jenny Broering, Nynikka Palmer, Robert Parker, Alexander Bell, Matthew Cooperberg, Peter Carroll. MP28-10 10-YEAR OUTCOMES IN WORK LOSS, PHYSICAL FUNCTION, AND MENTAL HEALTH OF 6,693 MEN UNDERGOING PRIMARY TREATMENT FOR PROSTATE CANCER. 2022. PMID:


  3. Borno HT, Zhang L, Zhang S, Kaplan C, Palmer NR, Bell A, Bakke B, Lin A, Aggarwal R, Small EJ. Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. 2022. PMID: 35584338


  4. Hiatt RA, Sibley A, Venkatesh B, Cheng J, Dixit N, Fox R, Ling P, Nguyen T, Oh D, Palmer NR, Pasick RJ, Potter MB, Somsouk M, Vargas RA, Vijayaraghavan M, Ashworth A. From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center. 2022. PMID: 35342686


  5. Hala T. Borno, Sylvia Zhang, Tracy Kuo Lin, Li Zhang, Nynikka R. Palmer, Christopher Nguyen, Celia Kaplan, Charles J. Ryan. Evaluating the impact of financial toxicity among cancer clinical trial participants. 2022. PMID:


  6. Samuel Washington, Peter Lonergan, Janet Cowan, Shoujun Zhao, Scott Greenberg, Jeanette Broering, Nynikka Palmer, Robert Parker, Alexander Bell, Matthew Cooperberg, Peter Carroll. MP19-14 LONGITUDINAL ANALYSIS OF THE INDIRECT BURDEN OF PROSTATE CANCER TREATMENT ON PAID AND UNPAID WORK: DATA FROM CAPSURE. 2021. PMID:


  7. Bell A, Lonergan PE, Escobar D, Fakunle M, Chu CE, Berdy S, Palmer NR, Breyer BN, Washington SL. A cross-sectional analysis of barriers associated with non-attendance at a urology telehealth clinic in a safety-net hospital. 2021. PMID: 34461145


  8. Samuel L. Washington, Peter E. Lonergan, Janet E. Cowan, Shoujun Zhao, Scott Greenberg, Jeanette M. Broering, Nynikka R. Palmer, Matthew R. Cooperberg, Peter R. Carroll. Abstract 686: Longitudinal analysis of the indirect burden of prostate cancer management on paid and unpaid work: Data from CaPSURE database. 2021. PMID:


  9. Palmer NR, Borno HT, Gregorich SE, Livaudais-Toman J, Kaplan CP. Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities. 2021. PMID: 34189651


  10. Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA. Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality. 2021. PMID: 33689041


  11. Elena Portacolone, Nynikka Palmer, Peter Lichtenberg, Catherine Waters, Carl Hill, Sahru Keiser, Julene K Johnson. Earning the Trust of African American Communities to Increase Representation in Dementia Research. 2020. PMID:


  12. Portacolone E, Palmer NR, Lichtenberg P, Waters CM, Hill CV, Keiser S, Vest L, Maloof M, Tran T, Martinez P, Guerrero J, Johnson JK. Earning the Trust of African American Communities to Increase Representation in Dementia Research. 2020. PMID: 33250619


  13. Balakrishnan AS, Palmer NR, Odisho AY. "Can you hear me now?": postoperative patient-initiated communication with providers. 2020. PMID: 33094946


  14. Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Pérez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L. Cancer health disparities in racial/ethnic minorities in the United States. 2020. PMID: 32901135


  15. Palmer NR, Shim JK, Kaplan CP, Schillinger D, Blaschko SD, Breyer BN, Pasick RJ. Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol. 2020. PMID: 32759241


  16. Nynikka R. Palmer, Richard L. Street, Dean Schillinger, Janet K. Shim, Sarah D. Blaschko, Benjamin N. Breyer, Rena J. Pasick. Abstract A047: An ethnographic study of African American men's prostate cancer treatment decision-making. 2020. PMID:


  17. Lisa T Wigfall, Susana Ramirez, Yamile Molina, Nynikka Palmer, Angelica M Roncancio, Daisy Y Morales-Campos. Abstract D029: What do veterans ages 27 years and older know and think about the HPV vaccine?. 2020. PMID:


  18. Palmer NR, Avis NE, Fino NF, Tooze JA, Weaver KE. Rural cancer survivors' health information needs post-treatment. 2020. PMID: 32147307


  19. Balakrishnan AS, Palmer NR, Fergus KB, Gaither TW, Baradaran N, Ndoye M, Breyer BN. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement. 2019. PMID: 30218761


  20. Borno HT, Lichtensztajn DY, Gomez SL, Palmer NR, Ryan CJ. Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer. 2018. PMID: 30444526


  21. Kaplan CP, Siegel A, Leykin Y, Palmer NR, Borno H, Bielenberg J, Livaudais-Toman J, Ryan C, Small EJ. A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy. 2018. PMID: 30272035


  22. Palmer NR, Gregorich SE, Livaudais-Toman J, Jih J, Kaplan CP. Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making. 2018. PMID: 29516434


  23. Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, Palmer N, Perkins A, Potter MB, Somsouk M, Vargas RA, van 't Veer LJ, Ashworth A. The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. Volume 37 of Issue 1. 2018. PMID: 29309234


  24. Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative. 2017. PMID: 29237415


  25. Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. 2017. PMID: 28826701


  26. E. Charles Osterberg, Nynikka Palmer, Catherine Harris, Gregory Murphy, Sarah Blaschko, Carissa Chu, Matthew Cooperberg, Peter Carroll, Benjamin Breyer. MP14-02 THE NATURAL HISTORY OF MEN ON ACTIVE SURVEILLANCE WITH LOW-RISK PROSTATE CANCER AT A SAFETY-NET, COUNTY HOSPITAL. 2017. PMID:


  27. Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM. Disparities in barriers to follow-up care between African American and White breast cancer survivors. 2015. PMID: 25821145


  28. Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. 2015. PMID: 25754547


  29. Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, Blanch-Hartigan D, Oakley-Girvan I, Hamilton AS, Weaver KE. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. 2014. PMID: 25403220


  30. Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE. Impact of rural residence on forgoing healthcare after cancer because of cost. 2013. PMID: 24097196


  31. Palmer NR, Geiger AM, Felder TM, Lu L, Case LD, Weaver KE. Racial/Ethnic disparities in health care receipt among male cancer survivors. 2013. PMID: 23678936


  32. Weaver KE, Palmer N, Lu L, Case LD, Geiger AM. Rural-urban differences in health behaviors and implications for health status among US cancer survivors. 2013. PMID: 23677333


  33. Palmer NR, Bartholomew LK, McCurdy SA, Basen-Engquist KM, Naik AD. Transitioning from active treatment: colorectal cancer survivors' health promotion goals. 2012. PMID: 23089464


  34. Palmer NR, Tooze JA, Turner AR, Xu J, Avis NE. African American prostate cancer survivors' treatment decision-making and quality of life. 2012. PMID: 22940374


  35. Naik AD, Palmer N, Petersen NJ, Street RL, Rao R, Suarez-Almazor M, Haidet P. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. 2011. PMID: 21403042


  36. Felder TM, Palmer NR, Lal LS, Mullen PD. What is the evidence for pharmaceutical patient assistance programs? A systematic review. 2011. PMID: 21317504


  37. McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men. 2005. PMID: 15854188